GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.
GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...
A task force has been set up to look into how to spend a £2m GSK legacy as the pharmaceutical giant closes its doors in Ulverston. Giles ...
“By exploring pre-cancer biology and building on GSK’s expertise in the science ... to drive forward the research and development of new medicines.
Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease ... “By exploring pre-cancer biology and building on GSK’s expertise in the science of ...
(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or ...